HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali Calderon-Aparicio Selected Research

Neoplasms (Cancer)

12/2021Prostate cancer: Alternatively spliced mRNA transcripts in tumor progression and their uses as therapeutic targets.
2/2021Roles of regulator of chromosome condensation 2 in cancer: Beyond its regulatory function in cell cycle.
12/2020Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function.
11/2020RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor.
1/2019Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status.
10/2015Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali Calderon-Aparicio Research Topics

Disease

6Neoplasms (Cancer)
12/2021 - 10/2015
2Melanoma (Melanoma, Malignant)
01/2019 - 10/2015
1Prostatic Neoplasms (Prostate Cancer)
12/2021
1Neoplasm Metastasis (Metastasis)
12/2021
1Colonic Neoplasms (Colon Cancer)
12/2020
1Esophageal Neoplasms (Esophageal Cancer)
11/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2019
1Breast Neoplasms (Breast Cancer)
10/2015

Drug/Important Bio-Agent (IBA)

2Transcription Factors (Transcription Factor)IBA
02/2021 - 11/2020
2tetrathiomolybdate (ammonium tetrathiomolybdate)IBA
01/2019 - 10/2015
2Disulfiram (Antabuse)FDA Link
01/2019 - 10/2015
2Chelating AgentsIBA
01/2019 - 10/2015
2CopperIBA
01/2019 - 10/2015
1ProteomeIBA
12/2021
1Messenger RNA (mRNA)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
02/2021
1ERRalpha Estrogen-Related ReceptorIBA
12/2020
1SOXB1 Transcription FactorsIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1neocuproineIBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1EnzymesIBA
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1U 0126 (UO 126)IBA
01/2019
11,10-phenanthrolineIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2015

Therapy/Procedure

3Therapeutics
12/2021 - 01/2019
1Radiotherapy
02/2021
1Drug Therapy (Chemotherapy)
02/2021